BE696026A - - Google Patents

Info

Publication number
BE696026A
BE696026A BE696026DA BE696026A BE 696026 A BE696026 A BE 696026A BE 696026D A BE696026D A BE 696026DA BE 696026 A BE696026 A BE 696026A
Authority
BE
Belgium
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24316060&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BE696026(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of BE696026A publication Critical patent/BE696026A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/22—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with radicals containing only hydrogen and carbon atoms, attached in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
BE696026D 1966-09-14 1967-03-23 BE696026A (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US57922266A 1966-09-14 1966-09-14

Publications (1)

Publication Number Publication Date
BE696026A true BE696026A (xx) 1967-09-25

Family

ID=24316060

Family Applications (1)

Application Number Title Priority Date Filing Date
BE696026D BE696026A (xx) 1966-09-14 1967-03-23

Country Status (11)

Country Link
US (1) US3507861A (xx)
JP (1) JPS4921155B1 (xx)
BE (1) BE696026A (xx)
CH (1) CH501011A (xx)
DE (1) DE1670625C3 (xx)
DK (1) DK123104B (xx)
ES (1) ES338498A1 (xx)
FR (1) FR6294M (xx)
NL (1) NL141515B (xx)
NO (1) NO133804C (xx)
SE (1) SE359841B (xx)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2063268A1 (de) * 1969-12-23 1971-07-08 Glaxo Laboratories Ltd , Greenford, Middlesex (Großbritannien) Antibiotika

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE29164E (en) * 1967-09-05 1977-03-29 Bristol-Myers Company 7-Amino-cephalosporanic and decephalosporanic acid derivatives
US3852282A (en) * 1969-04-01 1974-12-03 Squibb & Sons Inc Certain 2-substituted cephalosporins
US4000129A (en) * 1970-02-18 1976-12-28 Koninklijke Nederlandsche Gist-En Spiritusfabriek N.V. 6-aminopenicillanic acid sulfoxide silyl esters
US3668202A (en) * 1970-02-24 1972-06-06 Lilly Co Eli Process for preparing cepham compounds
US3668201A (en) * 1970-02-24 1972-06-06 Lilly Co Eli Cepham compounds
US3676434A (en) * 1970-07-29 1972-07-11 Lilly Co Eli Cephalosporin salts
US3714146A (en) * 1970-10-05 1973-01-30 Bristol Myers Co Novel syntheses of cephalexin and intermediates therefor
CA972362A (en) * 1970-10-12 1975-08-05 Hirotomo Masuya Penicillins and cephalosporins
US4175125A (en) * 1971-12-27 1979-11-20 Eli Lilly And Company Method for treating methicillin resistant staphylococcus aureus
JPS551272B2 (xx) * 1972-04-14 1980-01-12
US3923795A (en) * 1972-06-19 1975-12-02 Lilly Co Eli 2-Alkoxycephalosporins
US4056676A (en) * 1973-03-14 1977-11-01 Eli Lilly And Company Halogenated phenylthioacetamido cephalosporins
AR205537A1 (es) * 1973-05-10 1976-05-14 Fujisawa Pharmaceutical Co Procedimiento para la preparacion de derivados de acido 7-substituido fenilglicinamido - 3 - substituido - 3 - cefem - 4 - carboxilicos
DE2355078A1 (de) * 1973-11-03 1975-05-07 Bayer Ag Verfahren zur herstellung von 7-amino-delta hoch 3-cephem-derivaten
US4063019A (en) 1976-03-30 1977-12-13 E. R. Squibb & Sons, Inc. [[[(2,4-Dioxo-1-imidazolidinyl)amino]carbonyl]amino]-acetylcephalosporin derivatives
US4946838A (en) * 1981-07-13 1990-08-07 E. R. Squibb & Sons, Inc. Crystalline anhydrous aztreonam
ZA84584B (en) * 1983-01-28 1984-09-26 Bristol Myers Co Substituted vinyl cephalosporins
US4520022A (en) * 1983-01-28 1985-05-28 Bristol-Myers Company Substituted vinyl cephalosporins
US4600773A (en) * 1983-12-01 1986-07-15 Eli Lilly And Company Crystalline cephalexin hydrochloride monohydrate
US4775751A (en) * 1985-06-03 1988-10-04 Eli Lilly & Company Process for cephalexin hydrochloride alcoholates
US5908929A (en) * 1996-12-05 1999-06-01 Vitara Chemicals Limited Process for the manufacture of the antibiotic 7-(D-α-amino-α-phenylacetamido)-3-methyl-3-cephem-4-carboxylic acid (cephalexin) and pharmaceutically acceptable salts thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3131184A (en) * 1961-12-27 1964-04-28 Smith Kline French Lab Derivatives of 7-aminocephalosporanic acid
US3167550A (en) * 1962-11-13 1965-01-26 Smith Kline French Lab Derivatives of 7-aminocephalosporanic acid
US3324118A (en) * 1965-12-27 1967-06-06 Lilly Co Eli Phenalkylmercaptomethyl cephalosporins

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2063268A1 (de) * 1969-12-23 1971-07-08 Glaxo Laboratories Ltd , Greenford, Middlesex (Großbritannien) Antibiotika

Also Published As

Publication number Publication date
ES338498A1 (es) 1968-04-01
JPS4921155B1 (xx) 1974-05-30
DK123104B (da) 1972-05-15
DE1670625A1 (de) 1970-08-06
SE359841B (xx) 1973-09-10
CH501011A (de) 1970-12-31
DE1670625C3 (de) 1975-05-28
NL141515B (nl) 1974-03-15
DE1670625B2 (de) 1974-10-24
NO133804C (xx) 1976-06-30
NL6704294A (xx) 1968-03-15
FR6294M (xx) 1968-09-09
US3507861A (en) 1970-04-21
NO133804B (xx) 1976-03-22

Similar Documents

Publication Publication Date Title
AT281852B (xx)
AU428063B2 (xx)
AU424443B2 (xx)
AU414526B2 (xx)
AU417216B2 (xx)
AU415165B1 (xx)
AU421822B2 (xx)
AU433222B2 (xx)
AU5895065A (xx)
AU218666A (xx)
AU1144366A (xx)
AU1111066A (xx)
AU433620A (xx)
BE693612A (xx)
AU414093B2 (xx)
BE696026A (xx)
AU411645B2 (xx)
BE666282A (xx)
AU407778B2 (xx)
AU2390066A (xx)
AU1027866A (xx)
BE662818A (xx)
BE694711A (xx)
BE694466A (xx)
BE694225A (xx)

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: ELI LILLY AND CY

Effective date: 19870323